What is Actemra?
Actemra (also known as Tocilizumab) is a humanized interleukin-6 receptor inhibiting monoclonal antibody drug used to treat moderate to severe rheumatoid arthritis. It is also used to treat juvenile idiopathic arthritis and systematic juvenile idiopathic arthritis. The Food and Drug Administration (FDA) also approved the drug to be used to treat giant cell arteritis. The drug is manufactured by Roche through its subsidiary Genentech and was initially approved by the FDA in 2010.
What are the Side Effects of Actemra?
- Death From:
- Heart Attacks
- Heart Failure
- Lung Complications such as interstitial lung disease
- Allergic Reactions
- Chest pain
- Difficulty breathing
- Mild to Severe Stomach Pains
- Gastrointestinal Perforation
- More Common Side Effects
- Runny nose
- Sinus pain
- Sore throat
Some of these side effects were in high or higher rates than other competing drugs. Roche initially marketed Actemra as having fewer or none of the same side effects as its competitor drugs.
Why are There Lawsuits Related to Actemra?
While some of these side effects were reported by Roche and Genentech, the severe side effects related to heart attacks, fatal brain bleeding, heart failure, pancreatitis, and lung disease were not disclosed to the FDA, but instead were discovered during a separate investigation. The lawsuits are focused on Roche and Genentech’s failure to warn the public and the medical community of these possibly fatal side effects.
Legal Help Is Available For Actemra Users
If you or a loved one have been prescribed Actemra and have experienced any of the side effects above you may be entitled to compensation. The first thing you should do is speak with an experienced attorney to learn more about your rights. Feel free to contact us online or call us directly at 318.541.8188 to schedule your free consultation.